Statistics
Publications
20
Citations
2.4K
H-Index
17
Active since
1989
Thompson N. Doman is an author at Eli Lilly (United States) specializing in cancer immunotherapy, pharmacology, and oncology.
Publications per year
1989–2022
20
20
High-throughput assays for promiscuous inhibitors
Brian Y. Feng, Anang A. Shelat, Thompson N. Doman et al. · Nature Chemical Biology · 2005 · 337 citations
Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets
Ying Chen, Jeremy McGee, Xian‐Ming Chen et al. · PLoS ONE · 2014 · 136 citations · Full text
Life Sciences, Genetics, Oncology +17
1–5 of 20